Myeloma Multiple
Oncology
3
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
2
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Karyopharm TherapeuticsNEWTON, MA
2 programs1
1
SelinexorPhase 21 trial
CyclophosphamidePhase 1/21 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Karyopharm TherapeuticsSelinexor
Cartesian TherapeuticsDescartes 08
Karyopharm TherapeuticsCyclophosphamide
Clinical Trials (3)
Treatment of Selinexor in Combination With Clarithromycin, Pomalidomide and Dexamethasone for Relapsed Refractory Multiple Myeloma Patients
Start: Dec 2021Est. completion: Dec 2022
Phase 2Terminated
Descartes-08 Consolidation Treatment in Patients With High-Risk Multiple Myeloma High-Risk Multiple Myeloma Who Have Residual Disease After Induction Therapy
Start: Dec 2021Est. completion: Nov 2022
Phase 2Terminated
Pembrolizumab Cyclophosphamide and Lenalidomide for Patients With Relapsed Multiple Myeloma
Start: Aug 2017Est. completion: Aug 2017
Phase 1/2Withdrawn
Related Jobs in Oncology
Senior Research Associate, Immuno-Oncology
SystImmune
1m ago
$60K - $85K/yr
Research Associate I/II, Immuno-Oncology
SystImmune
1m ago
Office Administrator
SystImmune
1m ago
$60K - $80K/yr
Scientist/Sr Scientist
TwoStep Therapeutics
San Carlos
12m ago
Working Student Office Management Support (m/f/d)
Mindpeak
Hamburg
15m ago
Senior Medical Project Manager (m/f/d)
Mindpeak
Hamburg
15m ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space